Markel Earnings Calls
| Release date | Oct 29, 2025 |
| EPS estimate | $24.02 |
| EPS actual | $30.91 |
| EPS Surprise | 28.68% |
| Revenue estimate | 4.003B |
| Revenue actual | 2.72B |
| Revenue Surprise | -32.04% |
| Release date | Jul 30, 2025 |
| EPS estimate | $24.97 |
| EPS actual | $51.72 |
| EPS Surprise | 107.13% |
| Revenue estimate | 3.955B |
| Revenue actual | 4.603B |
| Revenue Surprise | 16.39% |
| Release date | Apr 30, 2025 |
| EPS estimate | $16.77 |
| EPS actual | $23.13 |
| EPS Surprise | 37.92% |
| Revenue estimate | 3.53B |
| Revenue actual | 4.218B |
| Revenue Surprise | 19.49% |
| Release date | Feb 05, 2025 |
| EPS estimate | $19.00 |
| EPS actual | $40.13 |
| EPS Surprise | 111.21% |
| Revenue estimate | 3.751B |
| Revenue actual | 3.841B |
| Revenue Surprise | 2.40% |
Last 4 Quarters for Markel
Below you can see how 0JYM.L performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 05, 2025 |
| Price on release | $1,853.04 |
| EPS estimate | $19.00 |
| EPS actual | $40.13 |
| EPS surprise | 111.21% |
| Date | Price |
|---|---|
| Jan 30, 2025 | $1,831.03 |
| Jan 31, 2025 | $1,830.95 |
| Feb 03, 2025 | $1,819.22 |
| Feb 04, 2025 | $1,834.75 |
| Feb 05, 2025 | $1,853.04 |
| Feb 06, 2025 | $2,015.08 |
| Feb 07, 2025 | $2,035.72 |
| Feb 10, 2025 | $2,003.23 |
| Feb 11, 2025 | $1,958.88 |
| 4 days before | 1.20% |
| 4 days after | 5.71% |
| On release day | 8.74% |
| Change in period | 6.98% |
| Release date | Apr 30, 2025 |
| Price on release | $1,797.57 |
| EPS estimate | $16.77 |
| EPS actual | $23.13 |
| EPS surprise | 37.92% |
| Date | Price |
|---|---|
| Apr 24, 2025 | $1,805.22 |
| Apr 25, 2025 | $1,795.62 |
| Apr 28, 2025 | $1,820.20 |
| Apr 29, 2025 | $1,810.65 |
| Apr 30, 2025 | $1,797.57 |
| May 01, 2025 | $1,834.95 |
| May 02, 2025 | $1,865.74 |
| May 05, 2025 | $1,874.90 |
| May 06, 2025 | $1,880.45 |
| 4 days before | -0.424% |
| 4 days after | 4.61% |
| On release day | 2.08% |
| Change in period | 4.17% |
| Release date | Jul 30, 2025 |
| Price on release | $2,017.79 |
| EPS estimate | $24.97 |
| EPS actual | $51.72 |
| EPS surprise | 107.13% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $2,011.09 |
| Jul 25, 2025 | $2,011.24 |
| Jul 28, 2025 | $2,026.48 |
| Jul 29, 2025 | $2,020.93 |
| Jul 30, 2025 | $2,017.79 |
| Jul 31, 2025 | $2,024.13 |
| Aug 01, 2025 | $1,961.00 |
| Aug 04, 2025 | $1,948.20 |
| Aug 05, 2025 | $1,952.26 |
| 4 days before | 0.333% |
| 4 days after | -3.25% |
| On release day | 0.314% |
| Change in period | -2.93% |
| Release date | Oct 29, 2025 |
| Price on release | $1,835.00 |
| EPS estimate | $24.02 |
| EPS actual | $30.91 |
| EPS surprise | 28.68% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $1,890.95 |
| Oct 24, 2025 | $1,879.03 |
| Oct 27, 2025 | $1,876.80 |
| Oct 28, 2025 | $1,855.84 |
| Oct 29, 2025 | $1,835.00 |
| Oct 30, 2025 | $1,928.14 |
| Oct 31, 2025 | $1,935.34 |
| Nov 03, 2025 | $1,974.53 |
| Nov 04, 2025 | $1,968.04 |
| 4 days before | -2.96% |
| 4 days after | 7.25% |
| On release day | 5.08% |
| Change in period | 4.08% |
Markel Earnings Call Transcript Summary of Q3 2025
Markel Group reported solid results through Q3 2025 with every reportable segment contributing positively. Management highlighted underwriting improvement at Markel Insurance (Q3 combined ratio ~93% vs. 97% a year ago), driven by portfolio pruning, pricing/terms actions and light catastrophe activity. The company reorganized reporting into four segments (Insurance, Industrial, Financial, Consumer & Other), introduced adjusted operating income (ex‑investment gains and amortization) as a core performance metric, and expanded disclosures to give investors clearer line‑of‑sight into segment performance. Adjusted operating income rose 24% year‑over‑year for the quarter to $621 million. Markel continues to generate strong operating cash flow (~$2.1 billion YTD), has been returning capital via buybacks (about $344 million repurchased YTD; share count down from ~13.8M in 2020 to 12.6M now), and remains disciplined on investments (equity returns 8.4% YTD; fixed income book yield 3.5% with 96% rated AA+ or better). Insurance execution priorities are: simplify the business, push accountability to P&L owners, invest in high‑potential areas (example: personal lines tech upgrade), and focus on combined ratio and ROE. Industrial and Consumer segments showed mixed performance (industrial revenues up but margins pressured by materials and auto weakness; Consumer aided by acquisitions/seasonality). Fronting/facilities business growth (including Nephila-related fronting) contributed meaningfully to insurance and financial segment revenues. Management emphasized continued share repurchases while remaining opportunistic about deploying capital to businesses or acquisitions that fit their disciplines.
Sign In
Buy 0JYM